Abstract:RNA interference (RNAi) inhibits gene expression by specifically degrading target mRNAs. Since the discovery of double-stranded small interference RNA (siRNA) in gene silencing(1), RNAi has become a powerful research tool in gene function studies. Compared to genetic deletion, RNAi-mediated gene silencing possesses many advantages, such as the ease with which it is carried out and its suitability to most cell lines. Multiple studies have demonstrated the applications of RNAi technology in cancer research. In particular, the development of the DNA vectorbased technology to produce small hairpin RNA (shRNA) driven by the U6 or H1 promoter has made long term and inducible gene silencing possible(2,3). Its use in combination with genetically engineered viral vectors, such as lentivirus, facilitates high efficiencies of shRNA delivery and/or integration into genomic DNA for stable shRNA expression.We describe a detailed procedure using the DNA vector-based RNAi technology to determine gene function, including construction of lentiviral vectors expressing shRNA, lentivirus production and cell infection, and functional studies using a mouse xenograft model.Various strategies have been reported in generating shRNA constructs. The protocol described here employing PCR amplification and a 3-fragment ligation can be used to directly and efficiently generate shRNA-containing lentiviral constructs without leaving any extra nucleotide adjacent to a shRNA coding sequence. Since the shRNA-expression cassettes created by this strategy can be cut out by restriction enzymes, they can be easily moved to other vectors with different fluorescent or antibiotic markers. Most commercial transfection reagents can be used in lentivirus production. However, in this report, we provide an economic method using calcium phosphate precipitation that can achieve over 90% transfection efficiency in 293T cells. Compared to constitutive shRNA expression vectors, an inducible shRNA system is particularly suitable to knocking down a gene essential to cell proliferation. We demonstrate the gene silencing of Yin Yang 1 (YY1), a potential oncogene in breast cancer(4,5), by a Tet-On inducible shRNA system and its effects on tumor formation. Research using lentivirus requires review and approval of a biosafety protocol by the Biosafety Committee of a researcher's institution. Research using animal models requires review and approval of an animal protocol by the Animal Care and Use Committee (ACUC) of a researcher's institution.

Functional siRNA expression from transfected PCR products

Construction of siRNA/miRNA expression vectors based on a one-step PCR process

Gene silencing in mammalian cells by PCR-based short hairpin RNA.

A PCR Based Method to Construct Small Interference RNA Expression Vectors.

Application of RNA Interference in Mammalian Cells

A Novel in Vitro Transcription Method for Producing Sirnas Without Specific Sequence Requirements

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Development of a species-specific RNA polymerase I-based shRNA expression vector

Research and Application on PCR Based siRNA Expression Cassettes

Primer Extension-Based Method for the Generation of a Sirna/mirna Expression Vector.

An Approach to Genomewide Screens of Expressed Small Interfering Rnas in Mammalian Cells

Short Rna Duplexes Produced By Hydrolysis With Escherichia Coli Rnase Iii Mediate Effective Rna Interference In Mammalian Cells

A novel siRNA validation system for functional screening of effective RNAi targets in mammalian cells and development of a derivative lentivirus delivery system

A Lentiviral Microrna-Based System for Single-Copy Polymerase II-regulated RNA Interference in Mammalian Cells

shRNA Transcribed by RNA Pol II Promoter Induce RNA Interference in Mammalian Cell

Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (sirnas) in Mammalian Cells

Construction and identification of a vector expressing siRNA in mammalian cells

An Automated High-Throughput Fluorescence In Situ Hybridization (FISH) Assay Platform for Use in the Identification and Optimization of siRNA-Based Therapeutics

[Preparation of Small Interfering RNA Expression Cassette Based on PCR Technique].

DNA Vector-Based RNA Interference to Study Gene Function in Cancer.

Development and Validation of Vectors Containing Multiple Sirna Expression Cassettes for Maximizing the Efficiency of Gene Silencing.